Ville Huovinen1, Virva Saunavaara2, Riku Kiviranta3, Miikka Tarkia2, Henri Honka2, Christoffer Stark4, Julius Laine4, Kaisa Linderborg5, Pasi Tuomikoski5, Robert Marcel Badeau2, Juhani Knuuti2, Pirjo Nuutila3, Riitta Parkkola6. 1. Turku PET Centre, University of Turku, PO Box 52, FI-20521 Turku, Finland; Department of Radiology, University of Turku, Medical Imaging Centre of Southwest Finland and Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland. 2. Turku PET Centre, University of Turku, PO Box 52, FI-20521 Turku, Finland. 3. Turku PET Centre, University of Turku, PO Box 52, FI-20521 Turku, Finland; Department of Endocrinology, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland. 4. Department of Surgery, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland. 5. Food Chemistry and Food Development, Department of Biochemistry, University of Turku, 20014 Turku, Finland. 6. Department of Radiology, Tampere University and Tampere University Hospital, PL 2000, 33521 Tampere, Finland; Department of Radiology, University of Turku, Medical Imaging Centre of Southwest Finland and Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland. Electronic address: riitta.parkkola@pshp.fi.
Abstract
OBJECTIVES: Diabetes induces osteoporosis and during osteoporosis, vertebral bone marrow (VBM) adipose tissue amount increases. The association between this adiposity and bone marrow metabolism is unclear. Here, we compared VBM glucose metabolism and fat content in healthy and diabetic pigs, in vivo, using positron emission tomography (PET), in-phase and out-of-phase magnetic resonance imaging and magnetic resonance proton spectroscopy ((1)H MR spectroscopy). MATERIALS/ METHODS: Eleven pigs (n=11) were used. The intervention group had five diabetic and the control group had six healthy pigs. To measure metabolism, PET-imaging with [(18)F]fluoro-deoxy-glucose ([(18)F]FDG) intravenous tracer was used. 1.5-T MRI with (1)H spectroscopy, in-phase and out-of-phase imaging and chemical TAG analysis of the VBM were performed. RESULTS: We found a significant inverse correlation between VBM glucose uptake (GU) and VBM fat content (R=-0.800, p<0.01) and TAG concentration assay (R=-0.846, p<0.05). There was a trend, although non-significant, of a linear correlation between VBM (1)H MR spectroscopy and TAG concentration (R=0.661) and (1)H MR spectroscopy and in-phase and out-of-phase MR imaging (R=0.635). CONCLUSIONS: VBM glucose metabolism coupled with VBM fat content may impact diabetic induced osteoporosis.
OBJECTIVES:Diabetes induces osteoporosis and during osteoporosis, vertebral bone marrow (VBM) adipose tissue amount increases. The association between this adiposity and bone marrow metabolism is unclear. Here, we compared VBM glucose metabolism and fat content in healthy and diabeticpigs, in vivo, using positron emission tomography (PET), in-phase and out-of-phase magnetic resonance imaging and magnetic resonance proton spectroscopy ((1)H MR spectroscopy). MATERIALS/ METHODS: Eleven pigs (n=11) were used. The intervention group had five diabetic and the control group had six healthy pigs. To measure metabolism, PET-imaging with [(18)F]fluoro-deoxy-glucose ([(18)F]FDG) intravenous tracer was used. 1.5-T MRI with (1)H spectroscopy, in-phase and out-of-phase imaging and chemical TAG analysis of the VBM were performed. RESULTS: We found a significant inverse correlation between VBM glucose uptake (GU) and VBM fat content (R=-0.800, p<0.01) and TAG concentration assay (R=-0.846, p<0.05). There was a trend, although non-significant, of a linear correlation between VBM (1)H MR spectroscopy and TAG concentration (R=0.661) and (1)H MR spectroscopy and in-phase and out-of-phase MR imaging (R=0.635). CONCLUSIONS: VBM glucose metabolism coupled with VBM fat content may impact diabetic induced osteoporosis.
Authors: Daniel G Whitney; Mark D Peterson; Maureen J Devlin; Michelle S Caird; Edward A Hurvitz; Christopher M Modlesky Journal: Am J Phys Med Rehabil Date: 2018-12 Impact factor: 2.159
Authors: Aino Latva-Rasku; Miikka-Juhani Honka; Alena Stančáková; Heikki A Koistinen; Johanna Kuusisto; Li Guan; Alisa K Manning; Heather Stringham; Anna L Gloyn; Cecilia M Lindgren; Francis S Collins; Karen L Mohlke; Laura J Scott; Tomi Karjalainen; Lauri Nummenmaa; Michael Boehnke; Pirjo Nuutila; Markku Laakso Journal: Diabetes Date: 2017-11-15 Impact factor: 9.461
Authors: Karla J Suchacki; Adriana A S Tavares; Domenico Mattiucci; Erica L Scheller; Giorgos Papanastasiou; Calum Gray; Matthew C Sinton; Lynne E Ramage; Wendy A McDougald; Andrea Lovdel; Richard J Sulston; Benjamin J Thomas; Bonnie M Nicholson; Amanda J Drake; Carlos J Alcaide-Corral; Diana Said; Antonella Poloni; Saverio Cinti; Gavin J Macpherson; Marc R Dweck; Jack P M Andrews; Michelle C Williams; Robert J Wallace; Edwin J R van Beek; Ormond A MacDougald; Nicholas M Morton; Roland H Stimson; William P Cawthorn Journal: Nat Commun Date: 2020-06-18 Impact factor: 14.919
Authors: Tam T Pham; Kaisa K Ivaska; Jarna C Hannukainen; Kirsi A Virtanen; Martin E Lidell; Sven Enerbäck; Keijo Mäkelä; Riitta Parkkola; Sauli Piirola; Vesa Oikonen; Pirjo Nuutila; Riku Kiviranta Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Ville Huovinen; Marco Bucci; Heta Lipponen; Riku Kiviranta; Samuel Sandboge; Juho Raiko; Suvi Koskinen; Kalle Koskensalo; Johan G Eriksson; Riitta Parkkola; Patricia Iozzo; Pirjo Nuutila Journal: PLoS One Date: 2016-09-26 Impact factor: 3.240